Rumadax 20 – Leflunomide Tablets IP 20 mg – 1 × 10 Tablets

Rumadax-20 Tablets feature Leflunomide, a potent immunomodulatory therapeutic agent belonging to the DMARD (Disease-Modifying Anti-Rheumatic Drug) class. It is clinically utilized for the continuous management of active Rheumatoid Arthritis (RA) to alleviate persistent symptoms and arrest tissue structural decline where standard non-steroidal pain medicines are insufficient.

Unlike simple analgesics that only mask localized pain, Rumadax-20 targets the underlying cellular processes of autoimmune joint destruction. Upon ingestion, leflunomide is rapidly metabolized into its active compound, teriflunomide. This active metabolite works by reversibly inhibiting the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH). This mechanical blockade shuts down the de novo pyrimidine synthesis pathway, which selectively prevents the rapid multiplication of hyperactive T-lymphocytes responsible for attacking the synovial linings of the joints. By curbing this immune-driven attack, Rumadax-20 effectively decreases systemic inflammatory cytokines, eliminates progressive morning stiffness, and halts structural erosion of cartilage and bone.

Key Benefits

• Disease-Modifying Action: Acts on root autoimmune channels to slow down chronic joint degeneration and bone erosion.

• Reduces Joint Swelling: Limits systemic immune over-activation to decrease fluid retention and tenderness inside the joint capsule.

• Enhances Daily Mobility: Effectively mitigates long-standing morning stiffness to improve walking and hand dexterity parameters.

• High-Strength Dosing: The 20 mg baseline layout is ideal for sustained daily maintenance cycles and reliable long-term clinical tracking in advanced cases.

• Trusted Quality: Manufactured under the high pharmaceutical benchmarks of Daxia Healthcare to guarantee accurate active ingredient uniformity.

Directions for Use

• Take exactly as directed by your rheumatologist or specialist.

• Swallow the tablet whole with a full glass of water. Do not crush, chew, or break it.

• Rumadax-20 can be taken with or without food. Try to maintain strict adherence by executing your dose at the exact same time every single day to keep blood levels steady.

• Noticeable therapeutic improvements typically manifest within 4 to 6 weeks, with maximum benefit occurring after several months of continuous treatment.

Safety & Precautions

• Do not modify your dose or stop taking this medication suddenly. Halting DMARD routines without specialist monitoring can lead to a severe, progressive flare-up of autoimmune joint inflammation.

• Contraindicated during pregnancy and breastfeeding: Leflunomide can cause severe birth defects or loss of a developing fetus. Highly effective contraception must be used by both men and women during treatment. If pregnancy is planned or suspected, stop the medicine and contact your specialist immediately for an accelerated drug elimination protocol.

• May cause minor side effects such as mild diarrhea, nausea, hair thinning, or a slight increase in blood pressure values.

• Periodic blood monitoring, including liver function tests (LFTs) and complete blood counts (CBC), is highly recommended, as leflunomide requires tracking for liver enzymes.

• Keep out of reach of children.

Storage

• Store in a cool, dry place below 30°C.

• Protect from direct sunlight, excessive heat, and environmental room moisture.

• Keep the tablets safely stored inside their original protective packaging configuration until the time of consumption.